Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 250

1.

Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?

Newton RU, Taaffe DR, Spry N, Cormie P, Chambers SK, Gardiner RA, Shum DH, Joseph D, Galvão DA.

BMC Cancer. 2012 Sep 26;12:432. doi: 10.1186/1471-2407-12-432.

2.

A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.

Newton RU, Taaffe DR, Spry N, Gardiner RA, Levin G, Wall B, Joseph D, Chambers SK, Galvão DA.

BMC Cancer. 2009 Jun 29;9:210. doi: 10.1186/1471-2407-9-210.

3.

A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial.

Galvão DA, Spry N, Taaffe DR, Denham J, Joseph D, Lamb DS, Levin G, Duchesne G, Newton RU.

BMC Cancer. 2009 Dec 2;9:419. doi: 10.1186/1471-2407-9-419.

4.

Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.

Cormie P, Galvão DA, Spry N, Joseph D, Chee R, Taaffe DR, Chambers SK, Newton RU.

BJU Int. 2015 Feb;115(2):256-66. doi: 10.1111/bju.12646. Epub 2014 Jul 27.

5.

Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial.

Galvão DA, Taaffe DR, Cormie P, Spry N, Chambers SK, Peddle-McIntyre C, Baker M, Denham J, Joseph D, Groom G, Newton RU.

BMC Cancer. 2011 Dec 13;11:517. doi: 10.1186/1471-2407-11-517.

6.

Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.

Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA.

J Clin Oncol. 2003 May 1;21(9):1653-9.

PMID:
12721238
7.

A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.

Lee CE, Leslie WD, Lau YK.

BMC Cancer. 2012 Mar 21;12:103. doi: 10.1186/1471-2407-12-103.

8.

Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review.

Gardner JR, Livingston PM, Fraser SF.

J Clin Oncol. 2014 Feb 1;32(4):335-46. doi: 10.1200/JCO.2013.49.5523. Epub 2013 Dec 16. Review.

PMID:
24344218
9.
10.

Long-term effects of androgen deprivation therapy in prostate cancer patients.

Basaria S, Lieb J 2nd, Tang AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS.

Clin Endocrinol (Oxf). 2002 Jun;56(6):779-86.

PMID:
12072048
11.
12.

Background to and management of treatment-related bone loss in prostate cancer.

Berruti A, Tucci M, Terrone C, Gorzegno G, Scarpa RM, Angeli A, Dogliotti L.

Drugs Aging. 2002;19(12):899-910. Review.

PMID:
12495366
13.

Bone health in men receiving androgen deprivation therapy for prostate cancer.

Eastham JA.

J Urol. 2007 Jan;177(1):17-24. Review.

PMID:
17161994
14.

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.

Grossmann M, Hamilton EJ, Gilfillan C, Bolton D, Joon DL, Zajac JD.

Med J Aust. 2011 Mar 21;194(6):301-6. Review.

PMID:
21426285
15.

Androgen deprivation therapy: evidence-based management of side effects.

Ahmadi H, Daneshmand S.

BJU Int. 2013 Apr;111(4):543-8. doi: 10.1111/j.1464-410X.2012.11774.x. Epub 2013 Jan 25. Review.

16.

Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies.

Cormie P, Chambers SK, Newton RU, Gardiner RA, Spry N, Taaffe DR, Joseph D, Hamid MA, Chong P, Hughes D, Hamilton K, Galvão DA.

BMC Cancer. 2014 Mar 18;14:199. doi: 10.1186/1471-2407-14-199.

17.

Quality of life in prostate cancer patients taking androgen deprivation therapy.

Dacal K, Sereika SM, Greenspan SL.

J Am Geriatr Soc. 2006 Jan;54(1):85-90.

PMID:
16420202
18.
19.

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

Nair B, Wilt T, MacDonald R, Rutks I.

Cochrane Database Syst Rev. 2002;(1):CD003506. Review.

PMID:
11869665
20.

A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.

Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, Lamb DS, Chambers SK, Newton RU.

Eur Urol. 2014 May;65(5):856-64. doi: 10.1016/j.eururo.2013.09.041. Epub 2013 Oct 3.

PMID:
24113319

Supplemental Content

Support Center